Anatara reaches required level for recruitment in trial for IBS treament
Anatara Life Sciences Ltd has successfully enrolled 60 people in its Stage 2 trial to test its Gastrointestinal ReProgramming (GaRP) treatment
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
